Incozen Therapeutics Pvt. Ltd.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Incozen Therapeutics Pvt. Ltd..The latest application filed is for "methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast n-oxide".

Company Profile

2.13.13

Incozen Therapeutics Pvt. Ltd. - Hyderabad IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Treating Autoimmune, Respiratory And Inflammatory Disorders By Inhalation Of Roflumilast N-oxide App 20220008400 - Vakkalanka; Swaroop K.	2022-01-13
Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast N-oxide Grant 11,103,488 - Vakkalanka August 31, 2	2021-08-31
3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases Grant 10,590,129 - Muthuppalaniappan , et al.	2020-03-17
Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine And 3,5-disubstituted -3h-[1,2,3]triazolo[4,5-b] Pyridine Compounds As Modulat App 20190218211 - Muthuppalaniappan; Meyyappan ; et al.	2019-07-18
3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases Grant 10,087,182 - Muthuppalaniappan , et al. October 2, 2	2018-10-02
Immunomodulator and anti-inflammatory compounds Grant 9,758,474 - Muthuppalaniappan , et al. September 12, 2	2017-09-12
Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine And 3,5-disubstituted-3h-[1,2,3]triazolo[4,5-b] Pyridine Compounds As Modulators Of Protein Kinases App 20170240542 - MUTHUPPALANIAPPAN; Meyyappan ; et al.	2017-08-24
Methods Of Treating Autoimmune, Respiratory And Inflammatory Disorders By Inhalation Of Roflumilast N-oxide App 20170196843 - Vakkalanka; Swaroop K.	2017-07-13
Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast N-oxide Grant 9,649,302 - Vakkalanka May 16, 2	2017-05-16
Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine And 3,5-disubstituted -3h-[1,2,3]triazolo[4,5-b] Pyridine Compounds As Modulators Of Protein Kinases App 20150133449 - MUTHUPPALANIAPPAN; Meyyappan ; et al.	2015-05-14
3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases Grant 8,912,331 - Muthuppalaniappan , et al. December 16, 2	2014-12-16
Novel Immunomodulator And Anti-inflammatory Compounds App 20140220050 - MUTHUPPALANIAPPAN; Meyyappan ; et al.	2014-08-07
Methods Of Treating Autoimmune, Respiratory And Inflammatory Disorders By Inhalation Of Roflumilast N-oxide App 20140213560 - VAKKALANKA; Swaroop K.	2014-07-31
Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine And 3,5-disubstituted -3h-[1,2,3]triazolo[4,5-b] Pyridine Compounds As Modulators Of Protein Kinases App 20130261116 - MUTHUPPALANIAPPAN; Meyyappan ; et al.	2013-10-03
3,5-Disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H[1,2,3]triazolo [4,5-b] Pyridine Compounds as Modulators of protein kinases Grant 8,481,739 - Muthuppalaniappan , et al. July 9, 2	2013-07-09
Novel Kinase Modulators App 20120059001 - MUTHUPPALANIAPPAN; Meyyappan ; et al.	2012-03-08
Novel Modulators Of Calcium Release-activated Calcium Channel And Methods For Treatment Of Non-small Cell Lung Cancer App 20110112058 - MUTHUPPALANIAPPAN; MEYYAPPAN ; et al.	2011-05-12
Novel Modulators Of Calcium Release-activated Calcium Channel App 20110105447 - Muthuppalaniappan; Meyyappan ; et al.	2011-05-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.